DNA Repair Flashcards

1
Q

What intrinsic features of DNA protect its integrity?

A

Thermodynamic super molecule
Energy needed to break DNA
Nucleobases on inside of helix.
Chromatin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What effect does cancer have on the mutation rate of cells?

A

Increases it.
Squamous epithelia - <1 per 10^8 base pair
In ovarian carcinoma - 75 per 10^8 base pair.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does melanin confer protection to keratinocytes from UVR?

A

melanosomes carry melanin from melanocytes to keratinocytes in basal layer of epidermis - assemble into supra nuclear caps.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does GST confer protection and what happens in cancer?

A

Links electrophilic compounds e.g. carcinogens to GSH –> detoxified, further metabolised and secreted. Lost from tumours due to promoter methylation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the mammalian equivalents of MutS and MutL?

A

MSH2/MSH3 (MSH3 mutated in colon, stomach, endometrial cancers)
MLH1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is MGMT and how is it protective?

A

O6-methyl DNA methyltransferase - removes methyl and ethyl adducts from O6 of guanine.
Treat mice with methylnitrosurea –> lymphomas.
Mice with functional genes develop cancers - over expression protects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is synthetic lethality?

A

Occurs between 2 genes when loss of one is compatible with cell viability, but loss of both is lethal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can HR proficient tumours be sensitised to PARP inhibitors?

A

Suppress HR by blocking recruitment of repair proteins to DSBs.
CDK1 inactivation reduces BRCA1 focus formation and renders BRCA1 proficient tumours sensitive to PARPis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What 2 drugs have been trialled?

A

Olaparib - 63% benefit in BRCA2 mutation carriers.

Iniparib + chemo - 56% clinical benefit in I group compared to chemo alone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly